Funding Opportunity Focused on Lung Cancers Harboring HER2 Mutations and/or Other HER2 Alterations NEW YORK, Jan. 7, 2025 /PRNewswire/ — Today, the Lung Cancer Research Foundation, in collaboration with Bayer Pharmaceuticals, announced submissions are being accepted for the $500,000,…
This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.